Javascript must be enabled to continue!
Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
View through CrossRef
Summary1 Muscarinic M1–M5receptors mediate the metabotropic actions of acetylcholine in the nervous system. A growing body of data indicate they also mediate autocrine functions of the molecule. The availability of novel and selective muscarinic agonists and antagonists, as well asin vivogene disruption techniques, has clarified the roles of muscarinic receptors in mediating both functions of acetylcholine.2 Selective M1agonists or mixed M1agonists/M2antagonists may provide an approach to the treatment of cognitive disorders, while M3antagonism, or mixed M2/M3antagonists, are approved for the treatment of contractility disorders including overactive bladder and chronic obstructive pulmonary disease. Preclinical data suggest that selective agonism of the M4receptor will provide novel anti‐nociceptive agents, while therapeutics‐based upon agonism or antagonism of the muscarinic M5receptor have yet to be reported.3 The autocrine functions of muscarinic receptors broadly fall into two areas – control of cell growth or proliferation and mediation of the release of chemical mediators from epithelial cells, ultimately causing muscle relaxation. The former particularly are involved in embryological development, oncogenesis, keratinocyte function and immune responsiveness. The latter regulate contractility of smooth muscle in the vasculature, airways and urinary bladder.4 Most attention has focused on muscarinic M1or M3receptors which mediate lymphocyte immunoresponsiveness, cell migration and release of smooth muscle relaxant factors. Muscarinic M4receptors are implicated in the regulation of keratinocyte adhesion and M2receptors in stem cell proliferation and development. Little data are available concerning the M5receptor, partly due to the difficulties in defining the subtype pharmacologically.5 The autocrine functions of acetylcholine, like those in the nervous system, involve activation of several muscarinic receptor subtypes. Consequently, the role of these subtypes in autocrine, as well neuronal cholinergic systems, significantly expands their importance in physiology and pathophysiology.
Title: Muscarinic receptor subtypes in neuronal and non‐neuronal cholinergic function
Description:
Summary1 Muscarinic M1–M5receptors mediate the metabotropic actions of acetylcholine in the nervous system.
A growing body of data indicate they also mediate autocrine functions of the molecule.
The availability of novel and selective muscarinic agonists and antagonists, as well asin vivogene disruption techniques, has clarified the roles of muscarinic receptors in mediating both functions of acetylcholine.
2 Selective M1agonists or mixed M1agonists/M2antagonists may provide an approach to the treatment of cognitive disorders, while M3antagonism, or mixed M2/M3antagonists, are approved for the treatment of contractility disorders including overactive bladder and chronic obstructive pulmonary disease.
Preclinical data suggest that selective agonism of the M4receptor will provide novel anti‐nociceptive agents, while therapeutics‐based upon agonism or antagonism of the muscarinic M5receptor have yet to be reported.
3 The autocrine functions of muscarinic receptors broadly fall into two areas – control of cell growth or proliferation and mediation of the release of chemical mediators from epithelial cells, ultimately causing muscle relaxation.
The former particularly are involved in embryological development, oncogenesis, keratinocyte function and immune responsiveness.
The latter regulate contractility of smooth muscle in the vasculature, airways and urinary bladder.
4 Most attention has focused on muscarinic M1or M3receptors which mediate lymphocyte immunoresponsiveness, cell migration and release of smooth muscle relaxant factors.
Muscarinic M4receptors are implicated in the regulation of keratinocyte adhesion and M2receptors in stem cell proliferation and development.
Little data are available concerning the M5receptor, partly due to the difficulties in defining the subtype pharmacologically.
5 The autocrine functions of acetylcholine, like those in the nervous system, involve activation of several muscarinic receptor subtypes.
Consequently, the role of these subtypes in autocrine, as well neuronal cholinergic systems, significantly expands their importance in physiology and pathophysiology.
Related Results
Deletion of p75NTR enhances the cholinergic innervation pattern of the visual cortex
Deletion of p75NTR enhances the cholinergic innervation pattern of the visual cortex
AbstractThe cholinergic system is involved in cortical plasticity, attention, and learning. Within the visual cortex the cholinergic system seems to play a role in visual perceptio...
PRESYNAPTIC MUSCARINIC-NICOTINIC MODULATION of GABAergic INPUTS to NEURONS in the REM SLEEP EXECUTIVE AREA of the ROSTRAL PONS
PRESYNAPTIC MUSCARINIC-NICOTINIC MODULATION of GABAergic INPUTS to NEURONS in the REM SLEEP EXECUTIVE AREA of the ROSTRAL PONS
ABSTRACT
A large body of evidence indicates that cholinergic neurons in the brainstem tegmental nuclei play a pivotal role in controlling neurons...
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry
Functional comparison of muscarinic partial agonists at muscarinic receptor subtypes hM1, hM2, hM3, hM4 and hM5 using microphysiometry
This study describes the pharmacological comparison of the muscarinic partial agonists sabcomeline, xanomeline and milameline at human cloned muscarinic receptor subtypes (hM1–5).
...
Do Pipecuronium and Rocuronium Affect Human Bronchial Smooth Muscle?
Do Pipecuronium and Rocuronium Affect Human Bronchial Smooth Muscle?
Background
Muscle relaxants affect nicotinic and muscarinic receptors. Interaction of muscle relaxants with muscarinic receptors of human airways has been studied incom...
Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting
Central blockade of muscarinic cholinergic receptors disrupts affective and attentional set‐shifting
AbstractImpairments in multiple aspects of attentional and executive function follow damage to cholinergic neurons in the central nervous system. Affective and attentional set‐shif...
Sub-type selective muscarinic acetylcholine receptors modulation for the treatment of parkinsonian tremor
Sub-type selective muscarinic acetylcholine receptors modulation for the treatment of parkinsonian tremor
Abstract
Parkinson’s Disease is characterized by hallmark motor symptoms including resting tremor, akinesia, rigidity, and postural instability. ...
Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus
Postsynaptic M1 and M3 receptors are responsible for the muscarinic enhancement of retrograde endocannabinoid signalling in the hippocampus
AbstractThe cholinergic system is crucial for higher brain functions including learning and memory. These functions are mediated primarily by muscarinic acetylcholine receptors (mA...
Muscarinic receptors downregulation is associated with increased IL6 expression in brain samples of individuals with schizophrenia
Muscarinic receptors downregulation is associated with increased IL6 expression in brain samples of individuals with schizophrenia
Acetylcholine plays a role in the immune system with notable
anti-inflammatory properties. Xanomeline, a muscarinic acetylcholine
receptor agonist, was recently approved for schizo...

